Rhythm Pharmaceuticals (STU:1RV) Price-to-Tangible-Book : 41.23 (As of May. 26, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rhythm Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-26), Rhythm Pharmaceuticals's share price is €34.06. Rhythm Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.83. Hence, Rhythm Pharmaceuticals's Price to Tangible Book Ratio of today is 41.23.

The historical rank and industry rank for Rhythm Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

STU:1RV' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.12 Med: 4.23 Max: 48.25
Current: 41.04

During the past 9 years, Rhythm Pharmaceuticals's highest Price to Tangible Book Ratio was 48.25. The lowest was 1.12. And the median was 4.23.

STU:1RV's Price-to-Tangible-Book is ranked worse than
97.95% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs STU:1RV: 41.04

A closely related ratio is called PB Ratio. As of today, Rhythm Pharmaceuticals's share price is €34.06. Rhythm Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was €0.93. Hence, Rhythm Pharmaceuticals's P/B Ratio of today is 36.66.

Rhythm Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Rhythm Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Price-to-Tangible-Book Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.48

7.69

1.88

6.36

16.57

Rhythm Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															4.62	5.32	7.09	16.57	45.76

Competitive Comparison of Rhythm Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Rhythm Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rhythm Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Rhythm Pharmaceuticals's Price-to-Tangible-Book falls into.

Rhythm Pharmaceuticals Price-to-Tangible-Book Calculation

Rhythm Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	34.06	/	0.826
	=	41.23

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Rhythm Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals (STU:1RV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (STU:1RV) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (STU:1RV) Headlines

No Headlines